Device Sports Med Visualization

N/A

Payments companies reported to CMS as associated with N/A. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.7Massociated payments (2023-2025)

5,361clinicians with associated payments

19companies reporting

By year

2023 $785K

2024 $457K

2025 $477K

Payments reported as associated with N/A, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurological Surgery $314K

Orthopaedic Surgery $310K

Orthopaedic Surgery of The Spine $302K

Otolaryngology $192K

Sports Medicine (Orthopaedic Surgery) $103K

Foot & Ankle Surgery $77K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with N/A

These are the largest totals companies reported as associated with N/A. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Shah-Nawaz Dodwad	Houston, TX	Orthopaedic Surgery of The Spine	$42,120.74
Deryk Jones	San Carlos, CA	Sports Medicine (Orthopaedic Surgery)	$34,728.43
Scott Faucett	Washington, DC	Orthopaedic Surgery	$33,900.39
Pablo Recinos	Cleveland, OH	Neurological Surgery	$32,400.00
Michael Chang	Mesa, AZ	Orthopaedic Surgery of The Spine	$32,236.88
Amon Ferry	Scottsdale, AZ	Sports Medicine (Orthopaedic Surgery)	$31,867.79
Daniel Refai	Atlanta, GA	Neurological Surgery	$31,470.34
Donald Gonzales	New Orleans, LA	Otolaryngology	$28,548.00
Haariss Ilyas	Cleveland, OH	Orthopaedic Surgery of The Spine	$27,859.83
Raj Sindwani	Cleveland, OH	Otolaryngology	$27,675.00

Prescribed N/A?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.